시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
말초동맥질환 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 질환별, 투여 경로별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Peripheral Artery Disease Market Size, Share, and Growth Analysis, By Type, By Treatment, By Disease, By Route of Administration, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1687600
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,665,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,967,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,268,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

말초동맥질환 시장 규모는 2023년 53억 달러로 평가되며, 2024년 58억 5,000만 달러에서 2032년 129억 1,000만 달러로 예측 기간(2025-2032년) 동안 10.4%의 CAGR로 성장할 것으로 예상됩니다.

2023년 10월 현재 40세 이상 미국인 중 약 650만 명이 말초동맥질환(PAD)을 앓고 있으며, 아프리카계 미국인의 발병률이 높은 것으로 시장 조사에서 밝혀졌습니다. 고령화 사회는 나이가 들수록 위험도가 높아지기 때문에 PAD 환자 증가를 크게 부추기고 있습니다. 이러한 인구통계학적 변화와 함께 PAD의 진단, 관리, 치료를 위한 제품 승인도 급증하고 있습니다. 이러한 요인들이 복합적으로 작용하여 PAD 발병의 전반적인 위험을 증가시키고 있으며, 이는 고령화, 질병 유병률 증가, 의료 기술 발전이 복합적으로 작용하고 있음을 보여줍니다. 이러한 역학관계를 이해하는 것은 미국에서 증가하는 PAD의 부담을 효과적으로 해결하려는 이해관계자들에게 매우 중요합니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

세계의 말초동맥질환 시장 규모 : 유형별·CAGR(2025-2032년)

세계의 말초동맥질환 시장 규모 : 치료법별·CAGR(2025-2032년)

세계의 말초동맥질환 시장 규모 : 질환별·CAGR(2025-2032년)

세계의 말초동맥질환 시장 규모 : 투여 경로별·CAGR(2025-2032년)

세계의 말초동맥질환 시장 규모 : 최종사용자별·CAGR(2025-2032년)

세계의 말초동맥질환 시장 규모·CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 제안

ksm
영문 목차

영문목차

Peripheral Artery Disease Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.91 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

As of October 2023, market insights reveal that around 6.5 million Americans aged 40 and older are living with Peripheral Artery Disease (PAD), with heightened susceptibility observed among African Americans. The aging population significantly drives the rise in PAD cases, as risks increase with age. In tandem with this demographic shift, there has been a surge in product approvals aimed at the diagnosis, management, and treatment of PAD. This combination of factors enhances the overall risk of developing PAD, highlighting the complex interplay of age-related trends, increasing disease prevalence, and technological advancements in healthcare. Understanding these dynamics is crucial for stakeholders aiming to address the growing burden of PAD in the United States effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segments Analysis

Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Artery Disease Market

The growing prevalence of elderly individuals affected by diabetes and hypertension serves as a critical driver for the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and hypertension contribute to the narrowing and hardening of arterial walls, which in turn restricts blood flow to the limbs, thus increasing the likelihood of PAD. As the number of seniors facing these health challenges continues to rise, the demand for effective PAD treatments and interventions is anticipated to grow, further propelling the market forward.

Restraints in the Peripheral Artery Disease Market

The anticipated recurrence of peripheral artery disease (PAD) following treatment is expected to present a significant barrier to the growth of the peripheral artery disease market in the upcoming years. Despite advancements in medical technology and treatment options, the risk of PAD relapse remains a considerable obstacle to continuous market development. Moreover, concerns related to product recalls within the industry may exacerbate difficulties for the PAD market in the short term. Such recalls can undermine consumer trust, invite increased regulatory scrutiny, and require corrective actions, all of which can hinder overall market growth and stability. Addressing these challenges will necessitate a collaborative approach from stakeholders to effectively manage disease and ensure product safety, thereby supporting the ongoing development of effective therapies for peripheral artery disease.

Market Trends of the Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) market is poised for significant growth, driven by the increasing prevalence of the disease and a surge in product approvals by regulatory bodies. As PAD, characterized by the narrowing of arteries that supply blood to the limbs, continues to affect a larger segment of the population, the demand for advanced diagnostic and therapeutic solutions becomes paramount. Recent advancements in medical technologies yield innovative treatments and management strategies, directly addressing the complexities of PAD. This favorable landscape indicates a robust market expansion, creating substantial opportunities for stakeholders in the healthcare sector over the coming years.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Peripheral Artery Disease Market Size by Type & CAGR (2025-2032)

Global Peripheral Artery Disease Market Size by Treatment & CAGR (2025-2032)

Global Peripheral Artery Disease Market Size by Disease & CAGR (2025-2032)

Global Peripheral Artery Disease Market Size by Route of Administration & CAGR (2025-2032)

Global Peripheral Artery Disease Market Size by End User & CAGR (2025-2032)

Global Peripheral Artery Disease Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기